Curofy
Sacubitril/Valsartan in Chronic Heart Failure
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function (ejection fraction).
See this content immediately after install